Thursday, 14 September 2017

U.S. FDA approves Bayer drug to treat follicular lymphoma

(Reuters) - The U.S. Food and Drug Administration said on Thursday it has approved Bayer AG's treatment for follicular lymphoma, a cancer of the lymph system.


No comments:

Post a Comment